Strengthening Families & Communities LLC Reduces Stock Holdings in Sanofi (NASDAQ:SNY)

Strengthening Families & Communities LLC lowered its holdings in shares of Sanofi (NASDAQ:SNY) by 9.7% in the 4th quarter, Holdings Channel.com reports. The firm owned 3,000 shares of the company’s stock after selling 321 shares during the quarter. Strengthening Families & Communities LLC’s holdings in Sanofi were worth $145,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Northwest Investment Counselors LLC bought a new stake in Sanofi during the third quarter valued at about $29,000. Synergy Asset Management LLC bought a new position in shares of Sanofi during the 4th quarter valued at approximately $25,000. Concord Wealth Partners increased its holdings in Sanofi by 157.8% in the 3rd quarter. Concord Wealth Partners now owns 593 shares of the company’s stock worth $34,000 after acquiring an additional 363 shares in the last quarter. Sunbelt Securities Inc. raised its stake in Sanofi by 72.1% during the 3rd quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock worth $43,000 after acquiring an additional 313 shares during the period. Finally, Fortitude Family Office LLC boosted its position in shares of Sanofi by 708.6% in the third quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock worth $43,000 after purchasing an additional 659 shares during the period. Institutional investors own 14.04% of the company’s stock.

Sanofi Stock Performance

Shares of NASDAQ SNY opened at $53.28 on Tuesday. The firm’s fifty day moving average is $49.82 and its two-hundred day moving average is $52.39. Sanofi has a 52-week low of $45.22 and a 52-week high of $58.97. The company has a market cap of $135.22 billion, a P/E ratio of 21.40, a P/E/G ratio of 0.99 and a beta of 0.57. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.74 and a current ratio of 1.46.

Sanofi (NASDAQ:SNY) last issued its earnings results on Thursday, January 30th. The company reported $0.70 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.70. Sanofi had a return on equity of 25.58% and a net margin of 12.77%. As a group, analysts anticipate that Sanofi will post 4.36 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft upgraded shares of Sanofi from a “sell” rating to a “hold” rating in a research report on Thursday, January 30th. StockNews.com lowered Sanofi from a “buy” rating to a “hold” rating in a research note on Thursday, December 12th. Finally, Sanford C. Bernstein raised Sanofi to a “strong-buy” rating in a report on Thursday, January 30th. Two research analysts have rated the stock with a hold rating, one has given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $60.00.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.